The fracture risk assessment tool (FRAX) has become the most popular predictor in clinical practice since it was developed by the World Health Organization in 2008, but a revision aims to resolve some ...

Credit: Shutterstock. Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types. Treatment with denosumab (Prolia ®) was associated with ...

Over half the women deemed very high risk are receiving treatment with therapies not recommended as first-line.

DENVER — Substantial reductions in fracture risk in postmenopausal women with osteoporosis seen after 18 months of treatment with the new osteoanabolic drug abaloparatide (Tymlos, Radius Health) are ...

Robot-assisted fracture reduction surgery represents a significant advancement in orthopaedic interventions, utilising robotics to achieve precise alignment of fractured bones. This technology ...

Fractures of the distal radius can be treated with below-elbow or above-elbow casts, however below-elbow casts may be associated with better radiological outcomes, based on results of a prospective ...

Overall, treatments that were associated with the greatest relative risk reduction in fragility fractures included teriparatide, abaloparatide, denosumab, romosozumab and most bisphosphonate. A ...

RevBio® announced today that TETRANITE, the company’s first of its kind regenerative "bone glue" has been approved for a ...

Giving zoledronate every 18 months for 6 years reduced the risk of fragility fractures—both vertebral and nonvertebral—in older women with hip bone mineral density indicating osteopenia, a ...

Please provide your email address to receive an email when new articles are posted on . Vitamin D3 supplementation did not reduce fracture risk in a large cohort of U.S. adults not selected for ...